Written by Klarity Editorial Team
Published: May 23, 2026

If you’re a psychiatrist or PMHNP treating depression, you’ve probably asked yourself: Can I legally prescribe antidepressants and other psychiatric medications via telehealth? The short answer is yes — but the details matter, especially when it comes to controlled substances, state-specific rules, and your scope of practice.
Let’s cut through the regulatory noise and get to what actually affects your practice.
Good news first: The DEA has extended COVID-era telehealth flexibilities through December 31, 2026. This means you can continue prescribing controlled substances via telemedicine without requiring an initial in-person visit — a massive win for psychiatric providers managing depression with comorbid conditions like anxiety or ADHD.
Here’s what matters for your day-to-day practice:
Non-controlled medications (SSRIs, SNRIs, bupropion, mirtazapine, etc.) have zero federal restrictions on telehealth prescribing. You can initiate and manage these medications entirely via video consultation, following the same standard of care as in-person treatment.
Controlled substances (benzodiazepines for anxiety, stimulants for ADHD, certain sleep medications) can be prescribed via telehealth under the current extension — but this is temporary. The Ryan Haight Act normally requires an in-person exam before prescribing any controlled substance via telemedicine, but that requirement has been suspended since March 2020 and will remain suspended through the end of 2026.
The DEA proposed new permanent rules in January 2025 that would formalize telehealth prescribing:
What this means for you: If you’re a psychiatrist treating depression with occasional ADHD co-management (requiring Schedule II stimulants), you’ll likely be able to continue telehealth prescribing after 2026 — you’ll just need to obtain a special DEA registration. PMHNPs may face more restrictions on Schedule II prescribing via telehealth under the proposed rules, though Schedule III–V (like certain anxiety medications) should remain accessible.
The bottom line: you can practice telepsychiatry for depression today without federal barriers, but plan for some administrative changes in 2027. Document your rationale for controlled substance prescribing, check your state’s prescription monitoring database, and keep standard-of-care documentation as tight as you would in person.
Your credentials determine what you can prescribe and whether you need physician oversight — and this varies dramatically by state.
Your scope is straightforward: you can diagnose and treat depression, prescribe all medications (including any controlled substance), and practice independently in all 50 states. No supervision requirements, no collaborative agreements. The only limitations are general medical regulations (licensure, DEA registration, standard of care).
For telehealth, this means you can:
Your scope depends entirely on your state’s nurse practice act. This is where things get complicated.
Full Practice Authority States (California, New York, Illinois):
In these states, experienced PMHNPs can practice completely independently — no physician supervision, no collaborative agreement.
Restricted Practice States (Texas, Florida, Pennsylvania):
In these states, you need a supervising or collaborating physician — even for telehealth.
What this means economically: If you’re a PMHNP in a restricted state, you’ll need to factor in the cost and logistics of maintaining a collaborative relationship. This might mean paying a psychiatrist for supervision, limiting your practice to certain settings, or partnering with a physician who’s willing to oversee your telehealth work. In full-practice states, you have much more freedom — and potentially higher income, since you’re not sharing revenue or paying supervision fees.
Federal law sets the floor, but states can add their own requirements. Here’s what you need to know for the major markets:
Telehealth friendly. No state-specific barriers.
PMHNP note: California’s AB 890 now allows experienced PMHNPs to practice independently, including via telehealth. This is a recent and major change — if you have the required experience, you don’t need physician oversight.
Telehealth allowed, but with specific restrictions.
PMHNP note: Texas requires a Prescriptive Authority Agreement with a physician. You’ll need a Texas-licensed MD/DO to supervise your practice, and Schedule II prescribing is extremely limited in outpatient settings.
Reality check: Texas has 246 of 254 counties designated as mental health shortage areas. The demand for telepsychiatry is enormous, but the regulatory environment is more restrictive than many states.
Psychiatry-friendly for telehealth, with a critical exception.
PMHNP note: Florida’s autonomous practice law excludes psychiatric NPs. You need a supervising psychiatrist and a protocol agreement on file with the Board of Nursing.
Progressive and telehealth-forward.
PMHNP note: Experienced NPs (3,600+ hours) have full practice authority with no written collaborative agreement required. You can run your own telehealth practice independently.
Permissive but lacking a comprehensive statute.
PMHNP note: You need a collaborative agreement with a physician. Pennsylvania has not passed NP independence legislation, so physician oversight is required.
One of the most progressive states for both telehealth and APRN practice.
PMHNP note: Full Practice Authority available after 4,000 hours of practice and additional training. With FPA, you can prescribe independently, including controlled substances (with consultation requirements for long-term Schedule II opioids).
Let’s talk about what everyone thinks about but few people discuss honestly: how do you actually get patients, and what does it cost?
If you’re thinking about building your own telehealth practice from scratch, here’s what you’re really looking at:
SEO and content marketing: You’ll need 6–12 months of consistent investment before seeing meaningful results. That means paying for website development, content creation, and ongoing optimization — typically $2,000–5,000/month with no guaranteed patient flow during the ramp-up period.
Google Ads: Mental health keywords cost $15–40+ per click. Most clicks don’t convert to booked appointments. When you factor in ad spend, testing, optimization, and the percentage of leads that actually show up, your cost per booked patient is realistically $200–400+ (sometimes much higher). And that’s after you’ve figured out what works — expect to burn through thousands in testing first.
Directory listings: Psychology Today charges a monthly fee and you compete with hundreds of other providers on the same page. Zocdoc charges per booking ($35–100+) plus a monthly subscription. Total monthly cost adds up fast, and qualified psychiatric leads are relatively rare compared to primary care.
The real cost of patient acquisition: When you add up agency fees, failed campaigns, staff time to handle and qualify leads, no-show rates from cold leads, and months of investment before results, acquiring a qualified psychiatric patient through DIY marketing typically costs $200–500+ per patient. And you’re gambling — there’s no guarantee any of it works.
This is where platforms like Klarity Health change the economics entirely.
Instead of spending $3,000–5,000/month on marketing with uncertain results, you pay only when a qualified patient books with you. No upfront marketing spend, no monthly subscriptions, no wasted ad spend on clicks that don’t convert.
What you get:
The economic reality: For most providers, especially those starting out or scaling, a platform that handles patient acquisition removes the risk entirely. You’re not gambling on SEO that might work in 12 months or burning money on Google Ads to figure out which keywords convert. You’re getting guaranteed ROI — every dollar you spend is on an actual patient appointment.
Your earning potential varies significantly by state based on:
Scope of practice: PMHNPs in full-practice states (CA, NY, IL) can operate independently and keep 100% of revenue. In restricted states, you’ll need to factor in supervision costs or revenue sharing with a collaborating physician.
Reimbursement rates: Telehealth parity laws in states like California, Illinois, and New York mean insurers pay the same for telehealth as in-person. States without parity may have lower reimbursement rates.
Market demand: Texas has massive unmet need (246 of 254 counties are mental health shortage areas) but restrictive NP rules. Florida allows out-of-state registration and has growing demand. New York has high reimbursement but requires a full license.
Regardless of where you practice, these fundamentals apply:
Get licensed in every state where your patients are located. Telehealth doesn’t change licensure requirements. Use the Interstate Medical Licensure Compact if you’re an MD/DO and your states participate.
Obtain a DEA registration in each state where you’ll prescribe controlled substances. PMHNPs need state-specific prescriptive authority as well.
Check your state’s Prescription Drug Monitoring Program (PDMP) before prescribing controlled substances. Most states require this, and failure to check can result in disciplinary action.
Use e-prescribing for controlled substances. Most states mandate it. Make sure your software is DEA-compliant (EPCS certified).
Document telehealth consent. Many states require explicit patient consent for telehealth services. Document that the patient understands they’re receiving care via telemedicine and that they agree to it.
Maintain the same standard of care as in-person. Conduct thorough psychiatric evaluations (including safety assessments for suicidality), document treatment plans, and coordinate care appropriately. Telehealth is not a shortcut — it’s a different modality with the same clinical responsibilities.
Have an emergency protocol. Know how to activate local emergency services if a patient is in crisis during a telehealth session. Document your emergency plan and discuss it with patients upfront.
Stay current on regulatory changes. The DEA is finalizing permanent rules, and several states are considering NP scope-of-practice expansions. Subscribe to updates from your state medical or nursing board and relevant professional organizations (APA, AANP, etc.).
Can I prescribe SSRIs via telehealth for a new patient I’ve never met in person?
Yes. Non-controlled antidepressants have no federal restrictions on telehealth prescribing. As long as you conduct an appropriate evaluation (via video or, in some states, audio) and meet your state’s standard of care, you can prescribe SSRIs, SNRIs, and other non-controlled medications entirely via telehealth.
What about benzodiazepines for a patient with depression and anxiety?
Under current federal rules (through December 31, 2026), you can prescribe benzodiazepines via telehealth for a new patient without an in-person visit. After 2026, you may need a special DEA telemedicine registration, but the proposed rules suggest Schedule III–V prescribing will remain accessible via telehealth.
Can I prescribe Adderall via telehealth for a patient with depression and ADHD?
Yes, under the current DEA extension through 2026. For 2027 and beyond, the DEA has proposed an ‘Advanced Telemedicine Prescribing’ registration specifically for psychiatrists (and certain other specialists) to prescribe Schedule II medications like stimulants via telehealth. If you’re a psychiatrist, this should remain accessible. PMHNPs may face more restrictions under the new rules.
What if my state requires a collaborative agreement but the physician is in a different state?
Your collaborating or supervising physician typically needs to be licensed in the state where you’re practicing. For example, if you’re a PMHNP practicing in Texas, your supervising physician must have a Texas license. Check your state’s specific requirements — some states allow out-of-state collaboration under certain conditions, but most require the supervising physician to be licensed locally.
Do I need malpractice insurance for telehealth?
Yes, and make sure your policy explicitly covers telehealth services. Some older policies exclude telemedicine or limit coverage by state. Verify that you’re covered for each state in which you practice via telehealth.
Can I see patients in multiple states?
Yes, but you need a license (or valid registration) in each state. Some states participate in licensure compacts (IMLC for physicians, eNLC for nurses in some cases) that can simplify multi-state practice. Florida offers an out-of-state telehealth registration for physicians. Most other states require full licensure.
What happens if the DEA extensions expire and permanent rules aren’t in place?
If the extensions lapse without new rules, the Ryan Haight Act’s original requirements would return — meaning you’d need an in-person exam before prescribing any controlled substance via telemedicine (with very limited exceptions). The DEA and HHS have repeatedly extended the flexibilities to avoid this ‘telemedicine cliff,’ and the proposed permanent rules suggest they intend to maintain access for psychiatric prescribing. Stay informed through DEA announcements and professional organizations.
Here’s the reality: telehealth for depression treatment is not only legal — it’s becoming the standard of care in many markets. The regulatory environment is moving in a favorable direction, with expansions in NP scope of practice, formalization of telehealth prescribing rules, and strong insurance parity laws in many states.
If you’re a psychiatrist, you have maximum flexibility. You can prescribe any medication necessary for treating depression via telehealth, practice independently, and expand across state lines (with appropriate licensure). The upcoming DEA rules are designed to accommodate your specialty specifically.
If you’re a PMHNP, your path depends heavily on your state. In full-practice states, you have nearly the same autonomy as a psychiatrist. In restricted states, you’ll need to navigate collaborative agreements — but the demand for your services is enormous, and many physicians are eager to partner with experienced NPs to expand access.
The economic opportunity is real — but only if you solve patient acquisition. DIY marketing is expensive, time-consuming, and risky. Platforms that handle patient acquisition for a per-appointment fee remove the uncertainty and let you focus on what you do best: treating patients.
The question isn’t whether you can prescribe antidepressants via telehealth. The question is: how will you build a sustainable, compliant, and profitable telehealth practice in your state?
Klarity Health connects depression-focused psychiatrists and PMHNPs with pre-qualified patients seeking medication management via telehealth. No upfront marketing costs, no wasted ad spend, no months of waiting for SEO to work — just qualified patients matched to your availability and expertise.
Explore how Klarity works and see if it’s the right fit for your practice: Join Klarity’s Provider Network
HHS Press Release – ‘HHS & DEA Extend Telemedicine Flexibilities for Prescribing Controlled Medications Through 2026’ (hhs.gov). Published January 2, 2026. Official announcement of DEA rule extension through December 31, 2026. https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html
DEA Press Release – ‘DEA Announces Three New Telemedicine Rules to Continue Open Access to Care’ (dea.gov). Published January 16, 2025. Details on proposed Special Registration for Telemedicine and Advanced Telemedicine Prescribing for psychiatrists. https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access
Ryan Haight Online Pharmacy Consumer Protection Act of 2008 – 21 U.S.C. §829(e). Federal law requiring in-person exam before prescribing controlled substances via telemedicine (currently suspended through DEA extensions).
Florida Statutes §456.47 – ‘Use of Telehealth to Provide Services’ (leg.state.fl.us). Florida law allowing out-of-state telehealth registration and psychiatric exception for Schedule II prescribing. https://www.leg.state.fl.us/statutes/index.cfm?Appmode=DisplayStatute&URL=0400-0499/0456/Sections/0456.47.html
Texas Administrative Code Title 22, Part 9 §174.5 – ‘Telemedicine Issuance of Prescriptions’ (txrules.elaws.us). Texas Medical Board rule on telehealth prescribing standards and chronic pain restrictions. Last updated January 15, 2025. https://txrules.elaws.us/rule/title22chapter174sec.174.5
Find the right provider for your needs — select your state to find expert care near you.